{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T09:41:18Z","timestamp":1783676478473,"version":"3.55.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"23-24","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.cca.2011.09.002","type":"journal-article","created":{"date-parts":[[2011,9,10]],"date-time":"2011-09-10T06:25:24Z","timestamp":1315635924000},"page":"2031-2036","source":"Crossref","is-referenced-by-count":6,"title":["Cytokeratins in hepatitis"],"prefix":"10.1016","volume":"412","author":[{"given":"Yusuf","family":"Yilmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2011.09.002_bb0005","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMcp1006613","article-title":"Clinical practice. Chronic hepatitis C infection","volume":"364","author":"Rosen","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2011.09.002_bb0010","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2011.09.002_bb0015","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/MOG.0b013e328337b0c4","article-title":"Recent advances in nonalcoholic fatty liver disease","volume":"26","author":"Cheung","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.cca.2011.09.002_bb0020","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2011.09.002_bb0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-1-60761-817-1_6","article-title":"The detection of hepatitis viruses","volume":"665","author":"Karayiannis","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.cca.2011.09.002_bb0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.virusres.2007.05.010","article-title":"Hepatitis viruses in the XXI century","volume":"127","author":"Cristina","year":"2007","journal-title":"Virus Res"},{"key":"10.1016\/j.cca.2011.09.002_bb0035","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1478-3231.2006.01422.x","article-title":"Hepatitis viruses: live and let die","volume":"27","author":"Herzer","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.cca.2011.09.002_bb0040","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.3748\/wjg.14.4725","article-title":"Hepatitis G virus","volume":"14","author":"Reshetnyak","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cca.2011.09.002_bb0045","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2741\/3685","article-title":"Chronic viral hepatitis: epidemiology, molecular biology, and antiviral therapy","volume":"16","author":"Gonzalez","year":"2011","journal-title":"Front Biosci"},{"key":"10.1016\/j.cca.2011.09.002_bb0050","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7861\/clinmedicine.9-6-613","article-title":"Recent advances in viral hepatitis","volume":"9","author":"Foster","year":"2009","journal-title":"Clin Med"},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2011.09.002_bb0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00535-010-0311-8","article-title":"Prevalence, gender, ethnic variations, and prognosis of NASH","volume":"46","author":"Hashimoto","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.cca.2011.09.002_bb0060","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cld.2007.02.013","article-title":"Metabolic syndrome and NASH","volume":"11","author":"Marchesini","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cca.2011.09.002_bb0065","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.bpg.2004.06.021","article-title":"Non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis (NAFLD\/NASH): diagnosis and clinical course","volume":"18","author":"Cortez-Pinto","year":"2004","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.cca.2011.09.002_bb0070","first-page":"390916","article-title":"Autoimmune hepatitis: a review of current diagnosis and treatment","volume":"2011","author":"Makol","year":"2011","journal-title":"Hepat Res Treat"},{"key":"10.1016\/j.cca.2011.09.002_bb0075","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1179\/acb.2008.066","article-title":"Donepezil-related toxic hepatitis","volume":"63","author":"Dierckx","year":"2008","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.cca.2011.09.002_bb0080","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.3748\/wjg.15.2669","article-title":"Ceftriaxone-induced toxic hepatitis","volume":"15","author":"Peker","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cca.2011.09.002_bb0085","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cld.2006.05.011","article-title":"Alcoholic hepatitis","volume":"10","author":"Sass","year":"2006","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cca.2011.09.002_bb0090","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1185\/030079905X56493","article-title":"Alcoholic hepatitis: from pathogenesis to treatment","volume":"21","author":"Sougioultzis","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.cca.2011.09.002_bb0095","doi-asserted-by":"crossref","unstructured":"Guido M, Mangia A, Faa G, et al. Chronic viral hepatitis: the histology report. Dig Liver Dis 201;43 Suppl 4:S331-43.","DOI":"10.1016\/S1590-8658(11)60589-6"},{"key":"10.1016\/j.cca.2011.09.002_bb0100","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cld.2008.07.003","article-title":"Disease-specific mechanisms of fibrosis: hepatitis C virus and nonalcoholic steatohepatitis","volume":"12","author":"van der Poorten","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cca.2011.09.002_bb0105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","article-title":"Evolving epidemiology of hepatitis C virus","volume":"17","author":"Lavanchy","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cca.2011.09.002_bb0110","first-page":"S108","article-title":"Diagnosing and treating hepatitis c virus infection","volume":"17","author":"Schiff","year":"2011","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.cca.2011.09.002_bb0115","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.3748\/wjg.v13.i36.4865","article-title":"Hepatitis C virus infection and apoptosis","volume":"13","author":"Fischer","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cca.2011.09.002_bb0120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.trsl.2006.11.010","article-title":"Pathogenesis of autoimmune hepatitis: from break of tolerance to immune-mediated hepatocyte apoptosis","volume":"149","author":"Lapierre","year":"2007","journal-title":"Transl Res"},{"key":"10.1016\/j.cca.2011.09.002_bb0125","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0168-8278(00)00110-0","article-title":"Apoptosis in alcoholic hepatitis: a novel therapeutic target?","volume":"34","author":"Day","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.cca.2011.09.002_bb0130","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.cca.2010.08.035","article-title":"Caspase-cleaved fragments of cytokeratin 18 in patients with chronic hepatitis B","volume":"411","author":"Eren","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2011.09.002_bb0135","first-page":"CR189","article-title":"Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C","volume":"15","author":"Yilmaz","year":"2009","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.cca.2011.09.002_bb0140","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3748\/wjg.v13.i6.837","article-title":"Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis","volume":"13","author":"Yilmaz","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cca.2011.09.002_bb0145","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2559.2009.03391.x","article-title":"Cytokeratin expression as an aid to diagnosis in medical liver biopsies","volume":"56","author":"Bateman","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.cca.2011.09.002_bb0150","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1139\/o95-068","article-title":"Cytokeratin expression, fibrillar organization, and subtle function in liver cells","volume":"73","author":"Marceau","year":"1995","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.cca.2011.09.002_bb0155","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.3748\/wjg.15.4387","article-title":"Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis","volume":"15","author":"Yilmaz","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cca.2011.09.002_bb0160","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/j.1365-2036.2009.04148.x","article-title":"Systematic review: caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease","volume":"30","author":"Yilmaz","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cca.2011.09.002_bb0165","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1586\/erm.10.14","article-title":"Utilization of cytokeratin-based biomarkers for pharmacodynamic studies","volume":"10","author":"Linder","year":"2010","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.cca.2011.09.002_bb0170","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000107582","article-title":"Cytokeratin markers come of age","volume":"28","author":"Linder","year":"2007","journal-title":"Tumour Biol"},{"key":"10.1016\/j.cca.2011.09.002_bb0175","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/172460089400900207","article-title":"Cytokeratins and tissue polypeptide antigen","volume":"9","author":"Sundstr\u00f6m","year":"1994","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.cca.2011.09.002_bb0180","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.clinbiochem.2004.05.009","article-title":"Clinical utility of cytokeratins as tumor markers","volume":"37","author":"Barak","year":"2004","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cca.2011.09.002_bb0185","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.bi.57.070188.003113","article-title":"Molecular and cellular biology of intermediate filaments","volume":"57","author":"Steinert","year":"1988","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.cca.2011.09.002_bb0190","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0955-0674(01)00301-5","article-title":"'Hard' and 'soft' principles defining the structure, function and regulation of keratin intermediate filaments","volume":"14","author":"Coulombe","year":"2002","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.cca.2011.09.002_bb0195","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev.bi.63.070194.002021","article-title":"Intermediate filaments: structure, dynamics, function, and disease","volume":"63","author":"Fuchs","year":"1994","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.cca.2011.09.002_bb0200","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0955-0674(05)80004-3","article-title":"The cellular and molecular biology of keratins: beginning a new era","volume":"5","author":"Coulombe","year":"1993","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.cca.2011.09.002_bb0205","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1242\/jcs.114.3.563","article-title":"Anomalous apical plasma membrane phenotype in CK8-deficient mice indicates a novel role for intermediate filaments in the polarization of simple epithelia","volume":"114","author":"Ameen","year":"2001","journal-title":"J Cell Sci"},{"key":"10.1016\/j.cca.2011.09.002_bb0210","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1083\/jcb.140.6.1441","article-title":"Lessons from keratin 18 knockout mice: formation of novel keratin filaments, secondary loss of keratin 7 and accumulation of liver-specific keratin 8-positive aggregates","volume":"140","author":"Magin","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cca.2011.09.002_bb0215","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1073\/pnas.072624299","article-title":"Keratin binding to 14-3-3 proteins modulates keratin filaments and hepatocyte mitotic progression","volume":"99","author":"Ku","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cca.2011.09.002_bb0220","first-page":"105","article-title":"Keratin modifications and solubility properties in epithelial cells and in vitro","volume":"31","author":"Omary","year":"1998","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.cca.2011.09.002_bb0225","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.yexcr.2007.04.024","article-title":"From Mallory to Mallory-Denk bodies: what, how and why?","volume":"313","author":"Zatloukal","year":"2007","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.cca.2011.09.002_bb0230","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1365-2559.2006.02416.x","article-title":"Histological assessment of non-alcoholic fatty liver disease","volume":"49","author":"H\u00fcbscher","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.cca.2011.09.002_bb0235","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1309\/VHHD-HTRU-N8J2-5X7R","article-title":"Portal tract eosinophils and hepatocyte cytokeratin 7 immunoreactivity helps distinguish early-stage, mildly active primary biliary cirrhosis and autoimmune hepatitis","volume":"116","author":"Goldstein","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cca.2011.09.002_bb0240","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s10620-008-0371-2","article-title":"Serum levels of keratin-18 fragments [tissue polypeptide-specific antigen (TPS)] are correlated with hepatocyte apoptosis in alcoholic hepatitis","volume":"54","author":"Gonzalez-Quintela","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cca.2011.09.002_bb0245","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/cbf.1774","article-title":"Apoptosis: why and how does it occur in biology?","volume":"29","author":"Ulukaya","year":"2011","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.cca.2011.09.002_bb0250","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/gut.2007.123943","article-title":"Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection","volume":"57","author":"Papatheodoridis","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.cca.2011.09.002_bb0255","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3851\/IMP1775","article-title":"Changes of serum levels of keratin-18 fragments in hepatitis B e antigen-negative chronic hepatitis B patients under oral antiviral therapy","volume":"16","author":"Giannousis","year":"2011","journal-title":"Antivir Ther"},{"key":"10.1016\/j.cca.2011.09.002_bb0260","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1743-422X-7-70","article-title":"Keratin 18 phosphorylation as a progression marker of chronic hepatitis B","volume":"7","author":"Shi","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.cca.2011.09.002_bb0265","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/hep.20277","article-title":"Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease","volume":"40","author":"Toivola","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2011.09.002_bb0270","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.20411","article-title":"Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury","volume":"40","author":"Bantel","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2011.09.002_bb0275","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/MCG.0b013e3181c0945a","article-title":"Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic fatty liver disease","volume":"44","author":"Papatheodoridis","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cca.2011.09.002_bb0280","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/jmv.21699","article-title":"Apoptosis markers related to pathogenesis of pediatric chronic hepatitis C virus infection: M30 mirrors the severity of steatosis","volume":"82","author":"Valva","year":"2010","journal-title":"J Med Virol"},{"key":"10.1016\/j.cca.2011.09.002_bb0285","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1478-3231.2006.01380.x","article-title":"Serum levels of cytokeratin-18 (tissue polypeptide-specific antigen) in liver diseases","volume":"26","author":"Gonzalez-Quintela","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.cca.2011.09.002_bb0290","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1515\/CCLM.2010.163","article-title":"Relationship between serum concentrations of keratin-18 and apoptosis in chronic hepatitis C","volume":"48","author":"Gonzalez-Quintela","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cca.2011.09.002_bb0295","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/MCG.0b013e318178d91f","article-title":"Severe hepatocellular injury with apoptosis induced by a hepatitis C polymerase inhibitor","volume":"43","author":"Feldstein","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cca.2011.09.002_bb0300","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1365-2893.2009.01251.x","article-title":"Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C","volume":"17","author":"Sgier","year":"2010","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.cca.2011.09.002_bb0305","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0024-3205(90)90598-L","article-title":"Ethanol-induced phosphorylation of cytokeratin in cultured hepatocytes","volume":"47","author":"Kawahara","year":"1990","journal-title":"Life Sci"},{"key":"10.1016\/j.cca.2011.09.002_bb0310","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0002-9440(10)64708-6","article-title":"Hepatocyte cytokeratins are hyperphosphorylated at multiple sites in human alcoholic hepatitis and in a mallory body mouse model","volume":"156","author":"Stumptner","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cca.2011.09.002_bb0315","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.alcohol.2006.01.003","article-title":"Serum cytokeratins in alcoholic liver disease: contrasting levels of cytokeratin-18 and cytokeratin-19","volume":"38","author":"Gonzalez-Quintela","year":"2006","journal-title":"Alcohol"},{"key":"10.1016\/j.cca.2011.09.002_bb0320","doi-asserted-by":"crossref","DOI":"10.1111\/j.1530-0277.2011.01570.x","article-title":"Synergistic effect of alcohol consumption and body mass on serum concentrations of cytokeratin-18","author":"Gonzalez-Quintela","year":"2011","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cca.2011.09.002_bb0325","doi-asserted-by":"crossref","first-page":"e17599","DOI":"10.1371\/journal.pone.0017599","article-title":"Serum markers of hepatocyte death and apoptosis are non invasive biomarkers of severe fibrosis in patients with alcoholic liver disease","volume":"6","author":"Lavallard","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2011.09.002_bb0330","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2036.2010.04556.x","article-title":"Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"33","author":"Dowman","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cca.2011.09.002_bb0335","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.numecd.2008.12.015","article-title":"Hepatic lipid metabolism and non-alcoholic fatty liver disease","volume":"19","author":"Tessari","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.cca.2011.09.002_bb0340","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.3748\/wjg.v16.i37.4652","article-title":"Roles of liver innate immune cells in nonalcoholic fatty liver disease","volume":"16","author":"Zhan","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cca.2011.09.002_bb0345","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2174\/092986711794480122","article-title":"Toward a biochemical diagnosis of NASH: insights from pathophysiology for distinguishing simple steatosis from steatohepatitis","volume":"18","author":"Yilmaz","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.cca.2011.09.002_bb0350","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hep.21223","article-title":"In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease","volume":"44","author":"Wieckowska","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2011.09.002_bb0355","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2217\/bmm.10.65","article-title":"Apoptosis in nonalcoholic steatohepatitis with normal aminotransferase values: zooming in on cytokeratin 18 fragments","volume":"4","author":"Yilmaz","year":"2010","journal-title":"Biomark Med"},{"key":"10.1016\/j.cca.2011.09.002_bb0360","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.cgh.2008.07.016","article-title":"Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients","volume":"6","author":"Diab","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cca.2011.09.002_bb0365","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/MPG.0b013e31817e2bfb","article-title":"Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease","volume":"47","author":"Vos","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cca.2011.09.002_bb0370","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1007\/s11695-008-9506-y","article-title":"A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH)","volume":"18","author":"Younossi","year":"2008","journal-title":"Obes Surg"},{"key":"10.1016\/j.cca.2011.09.002_bb0375","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/hep.23050","article-title":"Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study","volume":"50","author":"Feldstein","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2011.09.002_bb0380","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1440-1746.2008.05731.x","article-title":"The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease","volume":"24","author":"Malik","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cca.2011.09.002_bb0385","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1210\/jc.2009-1834","article-title":"Apoptotic markers indicate nonalcoholic steatohepatitis in polycystic ovary syndrome","volume":"95","author":"Tan","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2011.09.002_bb0390","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1386-6346(02)00277-2","article-title":"Aberrant cytokeratin expression and high susceptibility to apoptosis in autoimmune hepatitis","volume":"25","author":"Murota","year":"2003","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cca.2011.09.002_bb0395","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/hep.22149","article-title":"Identification of plasma membrane autoantigens in autoimmune hepatitis type 1 using a proteomics tool","volume":"47","author":"Tahiri","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2011.09.002_bb0400","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/lt.20404","article-title":"Antibodies against cytokeratin 8\/18 in a patient with de novo autoimmune hepatitis after living-donor liver transplantation","volume":"11","author":"Inui","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cca.2011.09.002_bb0405","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.yexmp.2010.07.004","article-title":"Novel insights into changes in biochemical properties of keratins 8 and 18 in griseofulvin-induced toxic liver injury","volume":"89","author":"Fortier","year":"2010","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.cca.2011.09.002_bb0410","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/hep.22622","article-title":"Is biopsy always necessary? Toward a clinico-laboratory approach for diagnosing nonalcoholic steatohepatitis in obesity","volume":"48","author":"Emanuele","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2011.09.002_bb0415","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.3748\/wjg.15.4346","article-title":"Biomarkers for noninvasive biochemical diagnosis of nonalcoholic steatohepatitis: tools or decorations?","volume":"15","author":"Yilmaz","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cca.2011.09.002_bb0420","first-page":"137","article-title":"Coinfection by hepatitis B virus and hepatitis C virus","volume":"3","author":"Pontisso","year":"1998","journal-title":"Antivir Ther"},{"key":"10.1016\/j.cca.2011.09.002_bb0425","first-page":"269","article-title":"Human immunodeficiency virus and hepatitis C virus coinfection","volume":"3","author":"Rockstroh","year":"1998","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.cca.2011.09.002_bb0430","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/hep.22691","article-title":"Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels","volume":"49","author":"Yilmaz","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2011.09.002_bb0435","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.22429","article-title":"Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes","volume":"48","author":"Fracanzani","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2011.09.002_bb0440","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22631","article-title":"Risk of severe liver disease in NAFLD with normal ALT levels: a pediatric report","volume":"48","author":"Manco","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2011.09.002_bb0445","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/hep.22336","article-title":"Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial","volume":"48","author":"Nobili","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2011.09.002_bb0450","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3177\/jnsv.56.271","article-title":"Serum cytokeratin 18 M30 antigen level and its correlation with nutritional parameters in middle-aged Japanese males with nonalcoholic fatty liver disease (NAFLD)","volume":"56","author":"Tabuchi","year":"2010","journal-title":"J Nutr Sci Vitaminol (Tokyo)"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898111004876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898111004876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T05:25:34Z","timestamp":1638595534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898111004876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":90,"journal-issue":{"issue":"23-24","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0009898111004876"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2011.09.002","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}